ArticleCytotechnology2021

Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response.

Daoyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.